Ibio (IBIO) traded down -7.69 % during a 24 hours period ending at 12:23 AM Central Europe on Tuesday 27th. One Ibio stock can currently be bought for about USD 0.71 on popular exchanges. Current supply of Ibio stocks is 64.3 mn. Ibio has a current market capitalization of USD 46.2 mn and approximately USD 470.8 k worth of Ibio was traded on exchanges in the last 24 hours. Since last month end, Ibio has traded -40 % down. Simple moving average of last 200 days is at USD 1.74. The highest price of past 52 weeks was recorded at USD 3.82 on 12/10/2025. 52 weeks low was at USD 0.71 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Mink Therapeutics (INKT) traded up 6.46 % and now trades at USD 10.43. Current market capitalisation for Mink Therapeutics is USD 54.7 mn.
Eva Live (GOAI) traded down -11.11 % and now trades at USD 1.01. Eva Live has a market capitalisation of USD 55.1 mn.
Clene (CLNN) traded flat 0 % and now trades at USD 3.84. Clene has a market capitalisation of USD 55.2 mn.
Gain Therapeutics (GANX) traded down -2.33 % and now trades at USD 1.15. Current market capitalisation for Gain Therapeutics is USD 55 mn.
Mindwalk (HYFT) traded down -3.33 % and now trades at USD 1.16. Mindwalk has a market capitalisation of USD 54.7 mn.
About Ibio
iBio, Inc. is a biopharmaceutical company based in Newark, United States, which specializes in the development and commercialization of novel plant-made products for preventing and treating serious infectious diseases.
